Graham A. MacGregor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Graham A. MacGregor has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Feng J. He
Blood Pressure Unit, St. George's Hospital Medical School, London, UK
6 shared publications- Feng J. He
Blood Pressure Unit, Cardiac and Vascular Sciences, St George's University of London, London, UK
4 shared publications Nirmala D. Markandu
From the Blood Pressure Unit, St. George’s Hospital Medical School, London, UK
4 shared publicationsF J He
Blood Pressure Unit, St. George's Hospital Medical School, London, UK
2 shared publicationsFeng J He
2 shared publicationsGiuseppe A. Sagnella
Blood Pressure Unit, St George’s Hospital Medical School, London, United Kingdom
2 shared publications
Latest Publications
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e503
PS 18-18 Economic evaluation of a school-based education programme to reduce salt intake in children and their families in China
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e503
PS 18-18 Economic evaluation of a school-based education programme to reduce salt intake in children and their families in China
- 1 October 2015
- Published by Elsevier in The Lancet
- Vol. 386, S34
Effect of salt reduction on iodine status in children and their families in northern China: a sub-study of a cluster-randomised controlled trial
- 1 October 2015
- Published by Elsevier in The Lancet
- Vol. 386, S34
Effect of salt reduction on iodine status in children and their families in northern China: a sub-study of a cluster-randomised controlled trial
- Open Access
- 22 September 2014
- Published by Wiley in Trends in Urology & Men's Health
- Vol. 5 (5) , 9-12
Salt intake and hypertension in men
- 22 September 2014
- Published by Wiley in Trends in Urology & Men's Health
- Vol. 5 (5) , 9-12
Open AccessSalt intake and hypertension in men
- Open Access
- 18 January 2013
- Published by Springer Nature
A randomized trial of sodium restriction and its effect on blood pressure in people of Asian descent
- 18 January 2013
- Published by Springer Nature
Open AccessA randomized trial of sodium restriction and its effect on blood pressure in people of Asian descent
- Open Access
- 17 January 2013
- Published by Springer Nature
A randomised trial of sodium restriction and its effect on blood pressure in people of African descent
- 17 January 2013
- Published by Springer Nature
Open AccessA randomised trial of sodium restriction and its effect on blood pressure in people of African descent
- Open Access
- 5 December 2012
- Published by Springer Nature
Combination Drug Treatment in Moderate-to-Severe Essential Hypertension.
- 5 December 2012
- Published by Springer Nature
Open AccessCombination Drug Treatment in Moderate-to-Severe Essential Hypertension.
- 1 February 2007
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (2) , 11
Response to Salt Intake in Children: Increasing Concerns?
- 1 February 2007
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (2) , 11
Response to Salt Intake in Children: Increasing Concerns?
- Open Access
- 1 September 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (9) , 1258-1259
Blood Pressure— Importance of Salt Intake
The totality of evidence for reducing salt, including epidemiologic, intervention, migration, treatment, animal and genetic studies, is stronger than for any of
- 1 September 2005
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (9) , 1258-1259
Open AccessBlood Pressure— Importance of Salt Intake
The totality of evidence for reducing salt, including epidemiologic, intervention, migration, treatment, animal and genetic studies, is stronger than for any of
- 1 July 2005
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (1) , 66-70
Modest Salt Reduction Lowers Blood Pressure in Isolated Systolic Hypertension and Combined Hypertension
Many randomized trials have shown that a reduction in salt intake lowers blood pressure in hypertensive individuals. However, few have looked at the effects according to hypertension category. A recent analysis of the third and fourth National Health and Nutrition Examination Survey suggests that salt intake may not be related to blood pressure in isolated systolic or combined hypertension. To look at this further, we reanalyzed the data of our previous salt reduction trials. Hypertensive individuals were studied in randomized double-blind crossover studies: 1 month of usual salt intake compared with 1 month of reduced salt intake. In isolated systolic hypertension (n=24), blood pressure was reduced from 166±19/86±7 to 156±20/85±7 mm Hg (systolic P P =0.459) with a reduction in urinary sodium from 175±51 to 87±38 mmol per 24-hour period (10.3 to 5.1 g per day of salt). In combined hypertension (n=88), blood pressure was reduced from 161±16/100±9 to 154±17/96±9 mm Hg ( P <0.001) with a reduction urinary sodium from 176±65 to 98±51 mmol per 24-hour period (10.4 to 5.8 g per day of salt). These results demonstrate that salt reduction has a significant effect on blood pressure in isolated systolic and combined hypertension. The fall in systolic observed in isolated systolic hypertension would be predicted to reduce stroke by approximately one third, ischemic heart disease by one quarter, and heart failure by one quarter in the population between 60 and 80 years of age, in whom isolated systolic hypertension is the predominate form of hypertension and carries the highest risk. These results provide strong support for universal salt reduction in all hypertensives.
- 1 July 2005
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (1) , 66-70
Modest Salt Reduction Lowers Blood Pressure in Isolated Systolic Hypertension and Combined Hypertension
Many randomized trials have shown that a reduction in salt intake lowers blood pressure in hypertensive individuals. However, few have looked at the effects according to hypertension category. A recent analysis of the third and fourth National Health and Nutrition Examination Survey suggests that salt intake may not be related to blood pressure in isolated systolic or combined hypertension. To look at this further, we reanalyzed the data of our previous salt reduction trials. Hypertensive individuals were studied in randomized double-blind crossover studies: 1 month of usual salt intake compared with 1 month of reduced salt intake. In isolated systolic hypertension (n=24), blood pressure was reduced from 166±19/86±7 to 156±20/85±7 mm Hg (systolic P P =0.459) with a reduction in urinary sodium from 175±51 to 87±38 mmol per 24-hour period (10.3 to 5.1 g per day of salt). In combined hypertension (n=88), blood pressure was reduced from 161±16/100±9 to 154±17/96±9 mm Hg ( P <0.001) with a reduction urinary sodium from 176±65 to 98±51 mmol per 24-hour period (10.4 to 5.8 g per day of salt). These results demonstrate that salt reduction has a significant effect on blood pressure in isolated systolic and combined hypertension. The fall in systolic observed in isolated systolic hypertension would be predicted to reduce stroke by approximately one third, ischemic heart disease by one quarter, and heart failure by one quarter in the population between 60 and 80 years of age, in whom isolated systolic hypertension is the predominate form of hypertension and carries the highest risk. These results provide strong support for universal salt reduction in all hypertensives.
- 1 January 2005
- Published by Taylor & Francis in Climacteric
- Vol. 8 (sup3) , 13-18
Importance of controlling blood pressure
Cardiovascular disease is the leading cause of death and disability world-wide. Blood pressure, throughout the range seen in developed countries, is the most important risk factor for cardiovascular disease. Lowering blood pressure within the whole population by lifestyle interventions, such as reducing dietary salt intake and increasing the consumption of fruit and vegetables, will be of great benefit. Blood pressure-lowering trials also demonstrate immense benefits in preventing strokes, heart failure and coronary heart disease. There are no differences in outcome between the different methods used to lower blood pressure and the benefit is proportional to the degree of blood pressure-lowering. Thiazide diuretics are effective in lowering blood pressure and have been the most widely prescribed blood pressure-lowering drugs. They work by causing both sodium and water loss, but also cause potassium loss and a fall in plasma potassium levels. The latter may mitigate the beneficial effects from blood pressure-lowering. Some diuretics, such as spironolactone, affect the distal tubule and do not cause a fall in plasma potassium levels. However, spironolactone has endocrine side-effects associated with the fact that it is not specific for the mineralocorticoid receptor. The development of a more selective aldosterone antagonist without endocrine side-effects could be a major advance as it would be able to oppose the effects of aldosterone, both on sodium retention and potassium loss and the other vascular effects.
- 1 January 2005
- Published by Taylor & Francis in Climacteric
- Vol. 8 (sup3) , 13-18
Importance of controlling blood pressure
Cardiovascular disease is the leading cause of death and disability world-wide. Blood pressure, throughout the range seen in developed countries, is the most important risk factor for cardiovascular disease. Lowering blood pressure within the whole population by lifestyle interventions, such as reducing dietary salt intake and increasing the consumption of fruit and vegetables, will be of great benefit. Blood pressure-lowering trials also demonstrate immense benefits in preventing strokes, heart failure and coronary heart disease. There are no differences in outcome between the different methods used to lower blood pressure and the benefit is proportional to the degree of blood pressure-lowering. Thiazide diuretics are effective in lowering blood pressure and have been the most widely prescribed blood pressure-lowering drugs. They work by causing both sodium and water loss, but also cause potassium loss and a fall in plasma potassium levels. The latter may mitigate the beneficial effects from blood pressure-lowering. Some diuretics, such as spironolactone, affect the distal tubule and do not cause a fall in plasma potassium levels. However, spironolactone has endocrine side-effects associated with the fact that it is not specific for the mineralocorticoid receptor. The development of a more selective aldosterone antagonist without endocrine side-effects could be a major advance as it would be able to oppose the effects of aldosterone, both on sodium retention and potassium loss and the other vascular effects.